Division of Drug Research, Department of Medical and Health Sciences , Linköping University , Linköping , Sweden ; Department of Nephrology UHL , County Council of Östergötland , Linköping , Sweden ; Department of Nephrology , Lund University , Lund , Sweden.
Department of Medicine , NÄL Hospital , Trollhättan , Sweden.
Clin Kidney J. 2012 Dec;5(6):549-51. doi: 10.1093/ckj/sfs098. Epub 2012 Oct 5.
Anti-glomerular basement membrane disease (anti-GBM) is usually characterized by rapidly progressive glomerulonephritis, and when autoantibody production has ceased, relapses are rare. Here, we report a 71-year-old women diagnosed at a stage of mild renal insufficiency. Over a period of 10 years, she experienced three mild relapses with return of anti-GBM antibodies, haematuria and slight elevations in serum creatinine level. All three relapses responded to immunosuppressive therapy, and all were preceded by peaks of myeloperoxidase-antineutrophil cytoplasm antibodies (MPO-ANCA). This case shows that long-term follow-up is warranted in patients treated for anti-GBM-mediated disease, but urinary dipsticks may be sufficient for early detection of relapses.
抗肾小球基底膜病(抗-GBM)通常以急进性肾小球肾炎为特征,当自身抗体产生停止后,复发很少见。在此,我们报告了一例 71 岁女性,在轻度肾功能不全阶段被诊断为该病。在 10 年的时间里,她经历了三次轻度复发,伴有抗-GBM 抗体、血尿和血清肌酐水平轻微升高。三次复发均对免疫抑制治疗有反应,且均在髓过氧化物酶-抗中性粒细胞胞质抗体(MPO-ANCA)峰值之前。该病例表明,抗-GBM 介导的疾病治疗后需要长期随访,但尿试纸检测可能足以早期发现复发。